, Domain , and Nuclear Localization Signal KEN Box , Bromo-Adjacent Homology a Proteasomal Pathway That Requires the Degradation of DNA Methyltransferase 1 by 5-Aza-Deoxycytidine Induces Selective

[1]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[2]  K. Ghoshal,et al.  DNA Methyltransferase 3b Regulates Nerve Growth Factor-Induced Differentiation of PC12 Cells by Recruiting Histone Deacetylase 2 , 2005, Molecular and Cellular Biology.

[3]  H. Leonhardt,et al.  Replication‐independent chromatin loading of Dnmt1 during G2 and M phases , 2004, EMBO reports.

[4]  M. Giacca,et al.  Subnuclear distribution of the largest subunit of the human origin recognition complex during the cell cycle , 2004, Journal of Cell Science.

[5]  James B. Mitchell,et al.  Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. , 2004, Cancer cell.

[6]  S. Belinsky,et al.  Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.

[7]  Gangning Liang,et al.  Preferential response of cancer cells to zebularine. , 2004, Cancer cell.

[8]  C. Plass,et al.  5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation* , 2004, Journal of Biological Chemistry.

[9]  K. Ghoshal,et al.  Identification of a Novel Cyclic AMP-response Element (CRE-II) and the Role of CREB-1 in the cAMP-induced Expression of the Survival Motor Neuron (SMN) Gene* , 2004, Journal of Biological Chemistry.

[10]  Guo-Jun Zhang,et al.  Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex , 2004, Nature.

[11]  K. Ghoshal,et al.  Role of Human Ribosomal RNA (rRNA) Promoter Methylation and of Methyl-CpG-binding Protein MBD2 in the Suppression of rRNA Gene Expression* , 2004, Journal of Biological Chemistry.

[12]  Z. Ronai,et al.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB , 2004, The EMBO journal.

[13]  R. Hoffman,et al.  Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. , 2003, Blood.

[14]  H. Kantarjian,et al.  DNA methylation in haematological malignancies: the role of decitabine , 2003, Expert opinion on investigational drugs.

[15]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[16]  M. Pagano,et al.  Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation , 2003, Cell.

[17]  R. Claus,et al.  Epigenetic targets in hematopoietic malignancies , 2003, Oncogene.

[18]  Yue-zhong Wu,et al.  Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas , 2003, Oncogene.

[19]  A. Jeltsch,et al.  Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme. , 2003, Journal of molecular biology.

[20]  M. Muller,et al.  Endogenous Assays of DNA Methyltransferases: Evidence for Differential Activities of DNMT1, DNMT2, and DNMT3 in Mammalian Cells In Vivo , 2003, Molecular and Cellular Biology.

[21]  K. Ghoshal,et al.  Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1 , 2003, Journal of cellular biochemistry.

[22]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[23]  K. Ghoshal,et al.  Inhibitors of Histone Deacetylase and DNA Methyltransferase Synergistically Activate the Methylated Metallothionein I Promoter by Activating the Transcription Factor MTF-1 and Forming an Open Chromatin Structure , 2002, Molecular and Cellular Biology.

[24]  C. Plass,et al.  Alterations of DNA methylation in hematologic malignancies. , 2002, Cancer letters.

[25]  Bruce Stillman,et al.  Structure and function of the BAH‐containing domain of Orc1p in epigenetic silencing , 2002, The EMBO journal.

[26]  J Wade Harper,et al.  The anaphase-promoting complex: it's not just for mitosis any more. , 2002, Genes & development.

[27]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[28]  G. Peters,et al.  Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. , 2002, Biochimica et biophysica acta.

[29]  C. Plass,et al.  Role of de Novo DNA Methyltransferases and Methyl CpG-binding Proteins in Gene Silencing in a Rat Hepatoma* , 2002, The Journal of Biological Chemistry.

[30]  Jan-Michael Peters,et al.  The anaphase-promoting complex: proteolysis in mitosis and beyond. , 2002, Molecular cell.

[31]  Albert Jeltsch,et al.  Beyond Watson and Crick: DNA Methylation and Molecular Enzymology of DNA Methyltransferases , 2002, Chembiochem : a European journal of chemical biology.

[32]  Xianglin Shi,et al.  Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin–proteasome pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[34]  G. Goodwin,et al.  The BAH domain, polybromo and the RSC chromatin remodelling complex. , 2001, Gene.

[35]  S. Tajima,et al.  Proliferation stage-dependent expression of DNA methyltransferase (Dnmt1) in mouse small intestine. , 2001, Cell structure and function.

[36]  T. Bestor,et al.  The DNA methyltransferases of mammals. , 2000, Human molecular genetics.

[37]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[38]  K. Ghoshal,et al.  Suppression of Metallothionein Gene Expression in a Rat Hepatoma Because of Promoter-specific DNA Methylation* , 2000, The Journal of Biological Chemistry.

[39]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[40]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[41]  E. Oakeley,et al.  Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. , 1998, Nucleic acids research.

[42]  T. Bestor,et al.  DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. , 1997, Journal of molecular biology.

[43]  Y. Liu,et al.  In differentiating mouse myoblasts DNA methyltransferase is posttranscriptionally and posttranslationally regulated. , 1996, Nucleic acids research.

[44]  R. Jaenisch,et al.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Chowdary,et al.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway , 1994, Molecular and cellular biology.

[46]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[47]  D. Santi,et al.  Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Christman,et al.  Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. , 1982, The Journal of biological chemistry.

[49]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[50]  S. Baylin.  Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin. , 2004, Novartis Foundation symposium.

[51]  M. Pagano,et al.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. , 2004, Nature.

[52]  M. Szyf,et al.  Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. , 2003, Carcinogenesis.

[53]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[54]  K. Ghoshal,et al.  Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I. , 2001, Gene expression.

[55]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[56]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[57]  T. Bestor,et al.  Cloning of a mammalian DNA methyltransferase. , 1988, Gene.

[58]  M. Voso,et al.  Background and Objectives. Methylation of DNA is a , 2022 .